Revolutionary 'four-target' drug could rival jabs with promise of 30% weight loss

Revolutionary 'four-target' drug could rival jabs with promise of 30% weight loss

Scientists have engineered a revolutionary weight loss medication that could rival the effectiveness of gastric surgery. The experimental drug achieves this by simultaneously activating four different hormone receptors rather than the three targeted by existing treatments, according to researchers at Tufts University.Headed by Robinson Professor of Chemistry Krishna Kumar, the research team developed what they term a "tetra-functional" molecule.…

Tufts scientists develop next-gen weight loss drug targeting four hormones

More than 15 million adults in the U.S.—about 4.5% of the population—are using popular weight loss drugs like Ozempic and Wegovy. While effective for many, these drugs can cause unpleasant side effects such as nausea, muscle loss, and even osteoporosis. They often require weekly injections and may stop working once treatment ends. But now, researchers […] The post Tufts scientists develop next-gen weight loss drug targeting four hormones appeare…